← Back to news

Markets

Stock Market Today: Dow Rises, Nasdaq Dives While Oracle Sinks; ATI, Penumbra Break Out (Live Coverage)

Y

Is Trex Company (TREX) Trading at an Attractive Valuation?

Y

Here’s What Impacted Knife River (KNF) in Q3

Y

Netflix Price Target Cut Again. Why the Stock Is Rising.

Y

Here’s How GLP-1 Affected MGP Ingredients (MGPI) in Q3

Y

1 Magnificent High-Yield Pipeline Stock Down 20% to Buy and Hold Forever

Y

Inspire Medical (INSP) Fell Due to Multiple Headwinds

Y

'A Modest Allocation Of 1% To 4% In Digital Assets Could Be Appropriate': Bank of America Opens Access To Bitcoin ETFs

Y

SoFi's CEO Believes It Could Become a Trillion-Dollar Company. Could It Actually Happen?

Y

Top Utility Stock Portland General Electric Checks All The Boxes

Y

A $3.68 Billion Infusion — And 400% Earnings Growth — Puts Reddit In Focus

Y

Cathie Wood's ARK Invest Obliterates Every ETF — But This One

Y

How Bailard became the best RIA to work for

Y

Earnings live: Oracle stock dives on AI bubble concerns. Broadcom results after the close offer the next test.

Y

BBH Select Series – Mid Cap Fund Sold Bright Horizons Family Solutions (BFAM) Following Share Price Appreciation

Y

Jim Cramer Says Alaska Air is Good “But as a Trading Vehicle Only”

Y

Jim Cramer on CoreWeave: “It’s a Very Well-Run Company By Michael Intrator”

Y

Jim Cramer on Dorman Products: “I’m Going to Have to Stay Away From That One”

Y

Jim Cramer Believes AeroVironment “Remains a Very Compelling Growth Story” Long Term

Y

Jim Cramer Discusses Marvell’s Stock Price Drop

Y

Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”

Y

Jim Cramer on Veeva: “Let’s Stay Away”

Y

Jim Cramer on Apple: “Bulls Like Me Were Considered Dreamers or Even Heretics”

Y

Jim Cramer Discusses How Warner Bros. Discovery Proved Doubters Wrong

Y

Daily Spotlight: Cleaning Up Shop

Y

Stocks making the biggest moves premarket: Oracle, Oxford Industries, Adobe, Gemini Space Station & more

F

Why Investors Are Turning to XAUT: Market Analysis and Gold Forecast Through 2026

Y

2 Genius Stocks That Could Double in 2026

Y

IBM’s $11B Deal Sends Confluent (CFLT) Into the Spotlight as Analysts Stay Bullish

Y

Wall Street Boosts Astera Labs (ALAB) PT as AI Infrastructure Demand Accelerates

Y

Do you manage your money like the top 1%? How to unlock the magical ‘15/65/20’ system whether you make $50K or $500K

Y

JPMorgan Points Out Lumentum Holdings’ (LITE) “Scale-Across” and “Multi-Rail” Opportunities

Y

Wells Fargo Boosts Lyft (LYFT) PT to $26 on Strong US Outlook, Remains Neutral Due to International Diversification Concerns

Y

Jefferies Maintains Hold Rating and $94 PT on Wayfair (W)

Y

Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application

Y

Dyne Therapeutics Shares Rise After Announcing Positive Topline Results for z-rostudirsen in Phase 1/2 DMD Trial

Y

Cannaccord Genuity Asserts Hold Stance on Caris Life Sciences, Inc. (CAI) On Oncology Pipeline Development

Y

Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update

Y

Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition

Y

H.C. Wainwright Keeps Buy on Madrigal Pharmaceuticals (MDGL) on Strong Rezdiffra Uptake and F2/F3 MASH Patient Data

Y

BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street

Y

Morgan Stanley Upgrades MP Materials (MP) to Overweight on US Supply Chain Push and Rare Earth Outlook

Y

H.C. Wainwright Lifts Ocular Therapeutix, Inc. (OCUL) Price Target Following Intravitreal Implant FDA Submission

Y

Bernstein Lowers Campbell’s (CPB) PT to $33, Cites Strong Broths/Premium Brands Despite Soup Struggles

Y

TD Cowen Lifts Praxis Precision Medicines Inc. (PRAX) Price Target amid NDA for Essential Tremor Treatment

Y

Morgan Stanley Raises Mirum (MIRM) PT to $95 on Strategic Bluejay Acquisition, Brelovitug Pipeline Addition

Y

Piper Sandler Confident in Oscar Health’s (OSCR) Market Share and Profitability Growth, Sets $404M Minimum 2027 Adjusted EBITDA Expectation

Y

Arcellx, Inc. (ACLX) Makes Progress on Multiple Myeloma Treatment

Y

Leerink Cuts BioMarin Pharmaceutical Inc. (BMRN) Price Target to $60, Citing Valuation and Competitive Challenges

Y

3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026

Y